The Box: Using Smart Technology to Improve One-year Outcome of Myocardial Infarction Patients (TheBox)
Studieoversikt
Detaljert beskrivelse
Rationale: Smart technology could improve quality of care in patients after acute myocardial infarction (AMI) with either ST or non-ST elevation.
Objective: The objective of this study is to measure the effect of a smart technology intervention on patients after AMI.
Study design: The design of the study is a single-center, open randomized-controlled trial.
Study population: The study population consists of patients who have been discharged from the ward of the cardiology department of the Leiden University Medical Center after primary percutaneous coronary intervention (PCI) for either ST or non-ST elevation myocardial infarction.
Intervention: Patients will be randomized to either "The Box" or regular follow-up. Patients who have been randomized to The Box will receive a box containing a smartphone compatible electrocardiogram (ECG) monitor, a weight scale, an activity tracker and a blood pressure monitor. If patients are randomized to The Box, two of the four outpatient clinic visits will be replaced by an e-consult, in which a patient does not have to go to the hospital, but talks with his or her doctor or nurse practitioner via a secured video connection.
Main study parameters/endpoints: The primary endpoint of the study will be the percentage of patients with controlled blood pressure in both groups.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Zuid-Holland
-
Leiden, Zuid-Holland, Nederland, 2333 ZA
- Leiden University Medical Center
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Patient is admitted with acute myocardial infarction
- Patient is able to communicate in English or Dutch at B1 level
Exclusion Criteria:
- Body Mass Index > 35 kg x m-2
- Included in another randomized controlled trial
- Patient is <18 years of age
- Patient is considered an incapacitated adult
- Patient is pregnant
- Patient is unwilling to sign the informed consent form
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: The Box
After randomization, patients in the intervention group will receive a box ("The Box") with all the devices described above.
Instructions about the installation and usage of the devices will be given.
Patients will be asked to measure their weight and blood pressure once a day.
Furthermore, patients will be asked to record an ECG using the AliveCor once a day.
Moreover, they are asked to record an ECG in case of any symptoms of possible cardiac origin, as judged by the patient.
All data will be automatically transferred to the Leiden University Medical Center.
Lastly, two of the four outpatient clinical visits will be done via a video connection.
The content of the interview will be comparable to the content of a regular outpatient clinic visit.
|
The Box contains four smartphone compatible devices.
Patients will measure their vital signs and automatically send them to the hospital.
|
|
Ingen inngripen: Control
Patients who are randomized to the control group will receive regular care.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Controlled Blood pressure
Tidsramme: One year
|
A blood pressure is considered controlled if the average of three measurements is below 140 (systolic) and 90 (diastolic) after 12 months of follow-up
|
One year
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Patient satisfaction of received care
Tidsramme: One year
|
Patient satisfaction, defined as the hight of scores derived from validated patient satisfaction questionnaire, will be measured in both groups.
|
One year
|
|
Major adverse cardiac events
Tidsramme: One year
|
Defined as cardiovascular death, recurrent STEMI, recurrent NST-ACS, revascularization, hospitalization for heart failure, TIA or ischaemic stroke
|
One year
|
|
Medication-adherence
Tidsramme: One year
|
Medication adherence is measured by validated medication adherence questionnaires.
This questionnaires asks if patients take their medicines in accordance to doctors advice.
|
One year
|
|
Physical activity
Tidsramme: One year
|
Measured by the iPAQ questionnaire
|
One year
|
|
Quality of life
Tidsramme: One year
|
Measured by the validated SF-36 questionnaire
|
One year
|
|
Healthcare utilization
Tidsramme: One year
|
Defined as the number of hospital visits, defined as an outpatient clinic visit, emergency care visit or admission for any reason.
This will be measured via questionnaires and verified by EMR data
|
One year
|
|
Percentage of patients in which a previously unknown sustained arrhythmia (30 seconds or more) is detected
Tidsramme: One year
|
One year
|
Samarbeidspartnere og etterforskere
Sponsor
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Treskes RW, van den Akker-van Marle ME, van Winden L, van Keulen N, van der Velde ET, Beeres S, Atsma D, Schalij MJ. The Box-eHealth in the Outpatient Clinic Follow-up of Patients With Acute Myocardial Infarction: Cost-Utility Analysis. J Med Internet Res. 2022 Apr 25;24(4):e30236. doi: 10.2196/30236.
- Treskes RW, van Winden LAM, van Keulen N, van der Velde ET, Beeres SLMA, Atsma DE, Schalij MJ. Effect of Smartphone-Enabled Health Monitoring Devices vs Regular Follow-up on Blood Pressure Control Among Patients After Myocardial Infarction: A Randomized Clinical Trial. JAMA Netw Open. 2020 Apr 1;3(4):e202165. doi: 10.1001/jamanetworkopen.2020.2165.
- Treskes RW, van Winden LA, van Keulen N, Atsma DE, van der Velde ET, van den Akker-van Marle E, Mertens B, Schalij MJ. Using Smart Technology to Improve Outcomes in Myocardial Infarction Patients: Rationale and Design of a Protocol for a Randomized Controlled Trial, The Box. JMIR Res Protoc. 2017 Sep 22;6(9):e186. doi: 10.2196/resprot.8038.
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- P16.070
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .